辅助放疗未降低伴静脉窦受累的WHO I级脑膜瘤复发:倾向评分分析及文献综述
结果显示辅助放疗未见获益(OR 2.51,95%CI 0.68-9.28,P=0.167),而上矢状窦受累增加复发风险(OR 12.69,95%CI 1.46-110.27,P=0.021)。
要点
- 辅助放疗未显著降低伴静脉窦受累的WHO I级脑膜瘤复发风险。
- 上矢状窦受累与复发风险升高独立相关。
- 全切除有降低复发风险的趋势,但未达统计学显著。
核心结论
- 辅助放疗似乎不是降低WHO I级脑膜瘤患者复发率的关键标准,即使静脉窦受累也是如此。
主要发现
- 34例(54.8%)接受辅助放疗,复发组接受辅助放疗的比例更高(77.8% vs. 45.5%,P=0.020)。
- 上矢状窦侵犯者接受放疗更频繁(76.5% vs. 50.0%,P=0.030),全切除后放疗较少(32.4% vs. 67.9%,P=0.005)。
- 倾向评分校正分析显示辅助放疗无获益(OR 2.51,95%CI 0.68-9.28,P=0.167),且不依赖于切除程度。
- 上矢状窦受累增加复发风险(OR 12.69,95%CI 1.46-110.27,P=0.021),全切除有降低复发趋势(OR 0.26,95%CI 0.06-1.09,P=0.065)。
临床怎么用
- 对于伴静脉窦受累的WHO I级脑膜瘤,辅助放疗不应作为常规推荐以降低复发。
- 上矢状窦受累患者应加强复发监测。
- 全切除可能有助于降低复发风险,应尽可能实现全切除。
局限性
- 倾向评分校正虽减少混杂,但无法排除未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Most meningiomas are classified as World Health Organization (WHO) grade I. Adjuvant radiation therapy (RT) is commonly recommended for subtotal resections with documented progressive regrowth of lesions with venous sinus involvement. We investigated if recurrence of WHO grade I meningiomas was influenced by adjuvant RT. METHODS: From 2000 to 2014, patients with grade I meningiomas with at least one venous sinus involvement and at least 4 years of follow-up were included. Demographics, venous sinus involvement, histology, and extent of resection (EOR) were characterized. Because patients undergoing RT tend to differ from those for whom adjuvant therapy was not prescribed, we used propensity scores to adjust for confounding variables. RESULTS: Sixty-two patients were included; of these, 18 (29.0%) had recurrences. The mean age was 52.8 ± 12.3 years, and 79.0% were women. A total of 34 cases (54.8%) were submitted to adjuvant RT. Adjuvant RT was more frequent in those who had tumor recurrence (77.8% vs. 45.5%, P = 0.020). RT was more frequent in superior sagittal sinus (SSS) invasion (76.5% vs. 50.0%, P = 0.030) and less prevalent after gross total resection (GTR) (32.4% vs. 67.9%, P = 0.005). Propensity score adjusted analysis suggested no adjuvant RT benefit (odds ratio [OR], 2.51; 95% confidence interval [CI], 0.68-9.28; P = 0.167), independent of the EOR. SSS involvement increased recurrence risk (OR, 12.69; 95% CI, 1.46-110.27; P = 0.021), whereas GTR tended to decrease it (OR, 0.26; 95% CI, 0.06-1.09; P = 0.065). CONCLUSIONS: Adjuvant RT does not seem to be a pivotal criterion to reduce the recurrence rate in patients with grade I meningioma, even when venous sinuses are involved.
引用
- Gomes Dos Santos A, Solla DJF, Moscardi R, et al. Adjuvant Radiotherapy Did Not Reduce Recurrence of World Health Organization Grade I Meningiomas with Venous Sinus Involvement: A Propensity Score Adjusted Analysis and Literature Review. World Neurosurg. 2019. PMID: 31306847. doi:10.1016/j.wneu.2019.07.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。